Akums Drugs and Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Akums Drugs and Pharmaceuticals has a total shareholder equity of ₹7.2B and total debt of ₹5.7B, which brings its debt-to-equity ratio to 78.5%. Its total assets and total liabilities are ₹35.2B and ₹28.0B respectively. Akums Drugs and Pharmaceuticals's EBIT is ₹3.8B making its interest coverage ratio 9.7. It has cash and short-term investments of ₹2.8B.
Belangrijke informatie
78.5%
Verhouding schuld/eigen vermogen
₹5.65b
Schuld
| Rente dekkingsratio | 9.7x |
| Contant | ₹2.77b |
| Aandelen | ₹7.20b |
| Totaal verplichtingen | ₹27.96b |
| Totaal activa | ₹35.16b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: AKUMS's short term assets (₹19.4B) exceed its short term liabilities (₹12.1B).
Langlopende schulden: AKUMS's short term assets (₹19.4B) exceed its long term liabilities (₹15.9B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: AKUMS's net debt to equity ratio (40%) is considered satisfactory.
Schuld verminderen: Insufficient data to determine if AKUMS's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: AKUMS's debt is well covered by operating cash flow (88.2%).
Rentedekking: AKUMS's interest payments on its debt are well covered by EBIT (9.7x coverage).